Effect of intrathecal baclofen delivered by an implanted programmable pump on health related quality of life in patients with severe spasticity

Journal of Neurology Neurosurgery and Psychiatry

Volumn 63, Issue 2, 1997, Pages 204-209

  Middel, Berrie ^a,b   Kuipers Upmeijer, Hanna ^b   Bouma, Jelte ^a   Staal, Michiel ^b   Oenema, Dettie ^b   Postma, Theo ^b   Terpstra, Sijmon ^b   Stewart, Roy ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Baclofen; Clinical outcomes; Health related quality of life

Indexed keywords

BACLOFEN; CENTRAL MUSCLE RELAXANT; DANTROLENE; TIZANIDINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FOLLOW UP; HEALTH BEHAVIOR; HEALTH STATUS; HUMAN; INTRATHECAL DRUG ADMINISTRATION; LONGITUDINAL STUDY; MALE; MENTAL HEALTH; MINIPUMP; MOBILIZATION; MULTICENTER STUDY; MUSCLE SPASM; ORAL DRUG ADMINISTRATION; PAIN; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; REST; SELF REPORT; SLEEP; SOCIAL PSYCHOLOGY; SPASTICITY; SYMPTOM;

EID: 0030825569     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.63.2.204     Document Type: Article

References (24)

1. Müller H, Zierski J, Dralle D, et al. Intrathecal baclofen in spasticity. In: Müller H, Zierski J, Penn RD, eds. Local spinal therapy of spasticity. Berlin-Heidelberg: Springer Verlag, 1988.
2. Nance P, Schryvers O, Schmidt B, et al. Intrathecal baclofen therapy for adults with spinal spasticity: therapeutic efficacy and effect on hospital admissions. Can J Neurol Sci 1995;22:22-9.
3. Albright L, Barron A, Fasick MP, et al. Continuous intrathecal baclofen infusion for spasticity of cerebral origin. JAMA 1993;270:247-57.
4. Coffey RJ, Cahill D, Steers W, et al. Intrathecal baclofen for intractable spasticity of spinal origin: results of a long-term multicenter study. J Neurosurg 1993;78:226-32.
5. Meythaler JM, Steers WD, Tuel SM, et al. Continuous intrathecal baclofen in spinal spasticity: a prospective study. Am J Phys Med Rehabil 1992;6:321-27.
6. Steinbok P, Daneshvar H, Evans D, Kestle JRW. Cost analysis of continuous intrathecal baclofen versus selective functional posterior rhizotomy in the treatment of spastic quadriplegia associated with cerebral palsy. Pediatr Neurosurg 1995;22:255-65.
7. Saltuari L, Kronenberg M, Marosi MJ, et al. Indication, efficiency and complications of intrathecal pump supported baclofen treatment in spinal spasticity. Acta Neurol Napoli 1992;3:187-94.
8. Ochs G, Delhaas EM. Long-term experience with intrathecal use of baclofen in severe spasticity. In: Lakke JPWF, Delhaas EM, Rutgers AWF, eds. Parental drug therapy in spasticity and Parkinson's disease. Carnforth: The Parthenon Publishing Group Limited, 1992.
9. Loubser PG, Narayan ChRK, Sandin KJ, et al. Continuous infusion of intrathecal baclofen: long-term effects on spasticity in spinal cord injury. Paraplegia 1991;29:48-64.
10. Teddy P, Jamous A, Gardner B, et al. Complications of intrathecal baclofen delivery. Br J Neurosurg 1992;6:115-8.
11. Penn RD. Intrathecal baclofen for spasticity of spinal origin: seven years of experience. J Neurosurg 1992;77:236-40.
12. Patterson V, Watt M, Byrnes D, et al. Management of severe spasticity with intrathecal baclofen delivered by a manually operated pump. J Neurol Neurosurg Psychiatry 1994;57: 582-5.
13. Bennett C, Franklin NL. Statistical analysis in chemistry and the chemical industry. New York: John Wiley, 1961.
14. Cohen J. A power primer. Psychol Bull 1992;1:155-9.
15. Zielhuis GA, Straatman H, Van 't Hof-Grootenboer AE, et al. The choice of a balanced allocation method for a clinical trial in otitis media with effusion. Stat Med 1990;9:237-46.
16. Ashworth B. Preliminary trial of carisoprodal in multiple sclerosis. Practitioner 1964;192:540-2.
17. Bergner M, Bobbitt RA, Carter WB, Gilson BS. The sickness impact profile: development and final revision of a health status measure. Med Care 1981;19:787-805.
18. De Bruin AF. The measurement of sickness impact: the construction of the SIP-68 [dissertation]. Maastricht: University of Limburg, 1994 (ISBN90-74421-02-4).
19. Luteyn F, Hamel LF, Bouman TK, et al. Hopkins symptom checklist (manual). Lisse: Swets and Zeitlinger, 1984.
20. Siegel S, Castellan NJ. Non-parametric statistics for the behavioural sciences. New York: McGraw-Hill, 1988.
21. Cohen J. Statistical power analyses for the behavioural sciences. New York: Academic Press, 1977.
22. McLean BN. Intrathecal baclofen in severe spasticity. Br J Hosp Med 1993;49:262-67.
23. Hugenholtz H, Nelson RF, Dehoux E, Bickerton R. Intrathecal baclofen for intractable spinal spasticity-a double blind cross-over comparison with placebo in 6 patients. Can J Neurol Sci 1992;19:188-95.
24. Azouvi P, Mane M, Thiebaut JB, Denys P, Remy-Neris O, Bussel B. Intrathecal baclofen administration for control of severe spinal spasticity: functional Improvement and longterm follow up. Arch Phys Med Rehabil 1996;77:35-9.